ImreNothMD
Pulmonology • Charlottesville, VACritical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Professor of Medicine
Dr. Noth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Hospital Dr
Fl 2
Charlottesville, VA 22908Phone+1 434-924-5219Fax+1 434-244-7509
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
University of California Davis HealthResidency, Internal Medicine, 1992 - 1995
University of Arizona College of MedicineClass of 1992
Certifications & Licensure
AZ State Medical License 1995 - Present
CA State Medical License 1993 - Present
VA State Medical License 2018 - 2026
IL State Medical License 1996 - 2020- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations Start of enrollment: 2005 Jan 01
- A Study of the Natural Progression of Interstitial Lung Disease (ILD) Start of enrollment: 2005 Sep 01
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 278 citationsAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Joyce S. Lee, Harold R. Collard, Kevin J. Anstrom, Fernando J. Martinez, Imre Noth
The Lancet. Respiratory Medicine. 2013-07-01 - 71 citationsResequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary FibrosisCamille M. Moore, Rachel Z. Blumhagen, Ivana V. Yang, Avram D Walts, Julie Powers
American Journal of Respiratory and Critical Care Medicine. 2019-07-15 - 99 citationsMicrobes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary FibrosisYong Huang, Shwu Fan Ma, Milena S. Espindola, Rekha Vij, Justin M. Oldham
American Journal of Respiratory and Critical Care Medicine. 2017-07-14
Other
- Management of the patient with severe COPD and cardiovascular diseaseNoth I, Schmidt GA
http://www.uptodate.com/contents/management-of-the-patient-with-severe-copd-and-cardiovascular-disea
UpToDate, Wolters Kluwer Health - 2013-02-12
Press Mentions
iTHRIV Backs Promising Researchers to Improve Patient CareJune 10th, 2024- Antibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyJune 4th, 2021
Ofev Doubles the Chance of Improving or Stabilizing IPFMay 26th, 2017- Join now to see all
Grant Support
- Genome-Wide Association And EXON Sequencing Study In IPFNational Heart, Lung, And Blood Institute2009–2010
- Combination Therapy In IPFNational Heart, Lung, And Blood Institute2005–2009
- FP And Salmeterol In Preventing COPD ExacerbationsNational Center For Research Resources2006–2007
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
